WEDNESDAY, April 4 (HealthDay News) — The incidence of head and neck cancers related to the human papillomavirus (HPV) is rising in the United States, with the greatest increase among middle-aged white men, a new study finds.
Tobacco and alcohol are the leading risk factors for head and neck cancers, but the sexually transmitted infection HPV is becoming an important risk factor as well, according to researchers from the Louisiana State University Health Sciences Center in New Orleans.
TUESDAY, April 3 (HealthDay News) — A new study finds that preteen girls are more likely than older teens and adult women to experience side effects after receiving the human papillomavirus (HPV) vaccine, Gardasil.
However, the side effects are not serious and are similar to those associated with other vaccines.
FRIDAY, March 23 (HealthDay News) — Anal human papillomavirus (HPV) infection and precancerous lesions are common among gay and bisexual men, but most of these cases will not progress to anal cancer, a new analysis of earlier research shows.
The researchers also found that the rate of progression from anal lesions to anal cancer among men appears to be much lower than the rate of progression from cervical lesions to cervical cancer among women.
By Maureen Salamon
HealthDay Reporter
WEDNESDAY, March 14 (HealthDay News) — The annual Pap smear may soon be a thing of the past, since new guidelines issued Wednesday say that most women need the cervical-cancer screening only once every three years.
In its first update since 2003, the U.S. Preventive Services Task Force (USPSTF) said a yearly Pap smear isn’t necessary for women aged 21 to 65, and that women younger than 21 don’t need the test at all because evidence indicates screening doesn’t lower cervical-cancer rates or deaths in this youngest group.
By Serena Gordon
HealthDay Reporter
MONDAY, Feb. 27 (HealthDay News) — The American Academy of Pediatrics on Monday renewed its call that all boys ages 11 and 12 receive the three-dose vaccine for the human papillomavirus (HPV).
The HPV vaccine has been available and recommended for girls and young women since 2006, because it’s highly effective at preventing cervical cancer. Since then, other cancers thought to be caused by HPV have increased, including anal cancer and some head and neck cancers.
By Serena Gordon
HealthDay Reporter
WEDNESDAY, Feb. 1 (HealthDay News) — The American Academy of Pediatrics is recommending that all boys between the ages of 11 and 12 receive the three-dose vaccine for the human papillomavirus (HPV).
That’s the most significant change in the latest immunization schedules, released Wednesday by the pediatrics group. The HPV vaccine has been available and recommended for girls and young women since 2006, because it was believed that the vaccine would be most effective at preventing cervical cancer. Since then, other cancers thought to be caused by HPV have been on the increase, including anal cancer and some head and neck cancers.
By Alan Mozes
HealthDay Reporter
THURSDAY, Jan. 26 (HealthDay News) — Almost 7 percent of American men and women are infected orally with the human papillomavirus (HPV), new research reveals, with men showing significantly higher infection rates than women.
In fact, the study found that among those between the ages of 14 and 69, men seem to face a nearly threefold greater risk than women for oral HPV infection.
THURSDAY, Jan. 26 (HealthDay News) — The human papillomavirus (HPV) vaccine Gardasil does not trigger autoimmune disorders such as rheumatoid arthritis, lupus, type 1 diabetes or multiple sclerosis, according to a two-year study that included nearly 190,000 girls and women.
Gardasil is recommended in the United States for girls and young women to protect them against HPV infection, which is the most common sexually transmitted disease in the United States and can lead to cervical cancer. A second HPV vaccine, GlaxoSmithKline’s Cervarix, is also approved to prevent infection with the virus.
By Kathleen Doheny
HealthDay Reporter
WEDNESDAY, Jan. 4 (HealthDay News) — Nearly one in four girls who gets the human papillomavirus (HPV) vaccine mistakenly thinks that her risk of getting other sexually transmitted diseases is lowered, a new study indicates.
HPV is the most commonly transmitted sexually transmitted infection (STI) in the United States, with nearly 30 percent of sexually active girls aged 14 to 19 infected. Some virus types can raise the risk for genital warts and cervical cancer.
By Amanda Gardner
HealthDay Reporter
WEDNESDAY, Dec. 21 (HealthDay News) — Jack Whelan first knew something was wrong when it got harder and harder to walk from the train station in Boston to the financial district where he worked.
He knew something was terribly wrong when he started getting nose bleeds.
| Text Size: |  |
|
